Anti-CD274 Antibody-Cytokine Fusion Protein, scfv (VS0624W2)-Neo2/15 (CAT#: VS-0624-FY87)

• Target
• PD-L1

• Molecule Class
• scfv-Neo2/15

• Species Reactivity
• Mouse

• Clone
• VS0624W2

• Related Disease
• Cancer

• Cytokine 1
• Neoleukin-2/15

• Cytokines 1 Description
• Neoleukin 2/15 is a computationally designed IL-2 mimetic that is intended to avoid common side effects.

• Cytokine 1 Species
• Synthetic construct

• Applications
• This product is for immuno therapy research. It can be used therapeutically to deliver biologically active ligands to a desired tissue.

• Introduction
• Every year, thousands of dogs are diagnosed with cancer. Canine cancers share many of the characteristics of human cancers, including tissue location, tumor progression, and response to chemotherapy and radiation. Unfortunately, the canine lymphocyte population is not as well defined as human lymphocytes, and reagents targeting the immune checkpoint pathway have not been widely used in veterinary research. Interruption of the programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway is an established and effective therapeutic strategy in human oncology and may also be effective in the treatment of canine cancers.

• Alternative Names
• CD274 Molecule; CD274 Antigen; B7 Homolog 1; Programmed Cell Death 1 Ligand 1; PDCD1 Ligand 1; PDCD1LG1; PDCD1L1

• Gene ID
• 29126

• UniProt ID
• Q9NZQ7

Select a product category from the dropdown menu below to view related products.